About
Managing Director at Red Tree with deep drug discovery and company-formation experience. Previously CEO of Inception Therapeutics and a venture partner at Versant Ventures, and an EIR at Third Rock Ventures. Holds a Ph.D. in molecular pharmacology from Stanford.
Contact· self-published, not guessed
Invests in
Biotech
Investments
Led
Belharra TherapeuticsChinook TherapeuticsLight Horse TherapeuticsLycia Therapeutics
Board seats
Biograph 55EBVioInversion TherapeuticsPhotinia
Per the firm's website.
Colleagues at Red Tree Venture
Adam Silverman
Red Tree Venture Labs Biologics at Red Tree Venture
Antonio Lepore
Senior Associate at Red Tree Venture
Ariell Ortega
Executive Assistant at Red Tree Venture
Bill Robinson
Scientific Advisory Board - Immunology; Chief, Stanford Division of Immunology and Rheumatology at Red Tree Venture
Brian Stearns
Red Tree Venture Labs Chemistry at Red Tree Venture
Cassie Lue
VP of Investor Relations at Red Tree Venture
Crystal Mackall
Scientific Advisory Board - Oncology; Director, Stanford Center for Cancer Cell Therapy at Red Tree Venture
Deborah Nguyen
Red Tree Venture Labs Operating Partner at Red Tree Venture
Frequently asked questions
- Who is Jeremy Caldwell?
- Managing Director at Red Tree with deep drug discovery and company-formation experience. Previously CEO of Inception Therapeutics and a venture partner at Versant Ventures, and an EIR at Third Rock Ventures. Holds a Ph.D. in molecular pharmacology from Stanford.
- Where does Jeremy Caldwell work?
- Jeremy Caldwell is Managing Director at Red Tree Venture.
- What does Jeremy Caldwell invest in?
- Jeremy Caldwell invests in Biotech.
- What boards does Jeremy Caldwell sit on?
- Jeremy Caldwell holds tracked board seats at Biograph 55, EBVio, Inversion Therapeutics, Photinia.
- What companies has Jeremy Caldwell invested in?
- Investments tracked here include Belharra Therapeutics, Chinook Therapeutics, Light Horse Therapeutics, Lycia Therapeutics.
- Does Jeremy Caldwell lead rounds?
- Yes — Jeremy Caldwell has led 4 tracked investments.